Cargando…
Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Glaucomatous neurodegeneration, a blinding disease affecting millions worldwide, has a need for the exploration of new and effective therapies. Previously, the glucagon-like peptide-1 receptor (GLP-1R) agonist NLY01 was shown to reduce microglia/macrophage activation, rescuing retinal ganglion cells...
Autores principales: | Lawrence, Emily C. N., Guo, Michelle, Schwartz, Turner D., Wu, Jie, Lu, Jingwen, Nikonov, Sergei, Sterling, Jacob K., Cui, Qi N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288152/ https://www.ncbi.nlm.nih.gov/pubmed/37362000 http://dx.doi.org/10.3389/fncel.2023.1156829 |
Ejemplares similares
-
Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma‐induced optic atrophy
por: Chen, Qianbo, et al.
Publicado: (2019) -
Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
por: Madeira, Maria H., et al.
Publicado: (2016) -
DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma
por: Kim, K-Y, et al.
Publicado: (2015) -
Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma
por: Geva, Michal, et al.
Publicado: (2021) -
The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy
por: Foldvari, Marianna, et al.
Publicado: (2016)